Summary
- Profile Type
- Research & Development Request
- POD Reference
- RDRGR20260226005
- Term of Validity
- 26 February 2026 - 26 February 2027
- Company's Country
- Greece
- Type of partnership
- Research and development cooperation agreement
- Targeted Countries
- Afghanistan
- Aland Islands
- Albania
- Algeria
- American Samoa
- Andorra
- Angola
- Anguilla
- Antarctica
- Antigua and Barbuda
- Aruba
- Australia
- Austria
- Azerbaijan
- Bahamas
- Bahrain
- Bangladesh
- Barbados
- Belarus
- Belgium
- Belize
- Benin
- Bermuda
- Bhutan
- Bolivia
- Bonaire, Saint Eustatius and Saba
- Bosnia and Herzegovina
- Botswana
- Bouvet Island
- Brazil
- British Indian Ocean Territory
- British Virgin Islands
- Brunei
- Bulgaria
- Burkina Faso
- Burundi
- Cabo Verde
- Cambodia
- Cameroon
- Canada
- Cayman Islands
- Central African Republic
- Chad
- Chile
- China
- Christmas Island
- Cocos Islands
- Colombia
- Comoros
- Cook Islands
- Costa Rica
- Croatia
- Cuba
- Curacao
- Cyprus
- Czechia
- Democratic Republic of the Congo
- Denmark
- Djibouti
- Dominica
- Dominican Republic
- Ecuador
- Egypt
- El Salvador
- Equatorial Guinea
- Eritrea
- Estonia
- Eswatini
- Ethiopia
- Falkland Islands
- Faroe Islands
- Fiji
- Finland
- France
- French Guiana
- French Southern Territories
- Gabon
- Gambia
- Georgia
- Germany
- Ghana
- Gibraltar
- Greece
- Greenland
- Grenada
- Guadeloupe
- Guam
- Guatemala
- Guernsey
- Guinea
- Guinea-Bissau
- Guyana
- Haiti
- Heard Island and McDonald Islands
- Honduras
- Hong Kong
- Hungary
- Iceland
- India
- Indonesia
- Iran
- Iraq
- Ireland
- Isle of Man
- Israel
- Italy
- Ivory Coast
- Jamaica
- Japan
- Jersey
- Jordan
- Kazakhstan
- Kenya
- Kiribati
- Kosovo
- Kuwait
- Kyrgyzstan
- Laos
- Latvia
- Lebanon
- Lesotho
- Liberia
- Libya
- Liechtenstein
- Lithuania
- Luxembourg
- Macao
- Madagascar
- Malawi
- Malaysia
- Maldives
- Mali
- Malta
- Marshall Islands
- Martinique
- Mauritania
- Mauritius
- Mayotte
- Mexico
- Micronesia
- Moldova
- Monaco
- Mongolia
- Montenegro
- Montserrat
- Morocco
- Mozambique
- Myanmar
- Namibia
- Nauru
- Nepal
- Netherlands
- Netherlands Antilles
- New Caledonia
- Nicaragua
- Niger
- Nigeria
- Niue
- Norfolk Island
- North Korea
- North Macedonia
- Northern Mariana Islands
- Norway
- Oman
- Pakistan
- Palau
- Palestinian Territory
- Panama
- Papua New Guinea
- Paraguay
- Peru
- Philippines
- Pitcairn
- Poland
- Portugal
- Puerto Rico
- Qatar
- Republic of the Congo
- Reunion
- Romania
- Russia
- Rwanda
- Saint Barthelemy
- Saint Helena
- Saint Kitts and Nevis
- Saint Lucia
- Saint Martin
- Saint Pierre and Miquelon
- Saint Vincent and the Grenadines
- Samoa
- San Marino
- Sao Tome and Principe
- Saudi Arabia
- Senegal
- Serbia
- Seychelles
- Sierra Leone
- Singapore
- Sint Maarten
- Slovakia
- Slovenia
- Solomon Islands
- Somalia
- South Africa
- South Georgia and the South Sandwich Islands
- South Sudan
- Spain
- Sri Lanka
- Sudan
- Suriname
- Svalbard and Jan Mayen
- Sweden
- Switzerland
- Syria
- Taiwan
- Tajikistan
- Tanzania
- Thailand
- Timor Leste
- Togo
- Tokelau
- Tonga
- Trinidad and Tobago
- Tunisia
- Türkiye
- Turkmenistan
- Turks and Caicos Islands
- Tuvalu
- U.S. Virgin Islands
- Uganda
- Ukraine
- United Arab Emirates
- United States
- United States Minor Outlying Islands
- Uruguay
- Uzbekistan
- Vanuatu
- Vatican
- Venezuela
- Vietnam
- Wallis and Futuna
- Western Sahara
- Yemen
- Zambia
- Zimbabwe
General information
- Short Summary
- A European organisation is coordinating GENIA, an Erasmus+ Alliances for Innovation project (ERASMUS-EDU-2026-PI-ALL-INNO-EDU-ENTERP) to address the pharmacogenomics skills gap in Europe. The project will develop HE and VET curricula and micro-credentials in clinical pharmacogenomics. Partners sought include universities, VET providers, hospital pharmacies, and clinical genetics laboratories.
- Full Description
- GENIA (Genomic Pharmacy & Personalised Medicine Skills Innovation Alliance) is an Erasmus+ Alliances for Innovation project (Lot 1: ERASMUS-EDU-2026-PI-ALL-INNO-EDU-ENTERP) addressing the critical pharmacogenomics skills gap across Europe. Despite growing policy momentum and infrastructure investment in precision medicine, fewer than 10% of pharmacy professionals feel adequately prepared to interpret and apply pharmacogenomic test results. GENIA establishes a Nordic-Mediterranean skills corridor connecting Europe’s most advanced genomic medicine ecosystems with its largest implementation frontiers. The project will design, develop and pilot: (1) an HE curriculum module on clinical pharmacogenomics for pharmacy and medical students (EQF 6-7); (2) a VET curriculum for genomic laboratory technicians (EQF 5); (3) a micro-credential programme for practising pharmacists and physicians; and (4) two ESCO-compliant occupational profiles. Curricula will be co-designed with enterprise partners through skills needs analysis, then piloted with at least 300 learners. The project directly supports the EU Deep Tech Talent Initiative, building workforce capacity in genomics and AI-enabled healthcare. A clinical decision support simulator will enable learners to practise integrating genomic information into prescribing workflows. All resources will be available as Open Educational Resources. The consortium seeks partners with expertise in pharmacy/medical education, VET curriculum development, clinical pharmacogenomics, bioinformatics and genomic laboratory practice.
- Advantages and Innovations
- GENIA’s innovation is structured around real clinical implementation and portable credentials. Training follows an end-to-end pharmacogenomics clinical workflow (order-interpret-act-document), structured into stackable micro-credential units. Competence is validated through safety-critical OSCE-style cases and supervised workplace evidence co-signed by clinical mentors. A clinical decision support simulator mirrors EHR-like tasks and generates an auditable performance trail feeding an e-portfolio for credential award. Credentials are issued as interoperable digital packs (badge + transcript + skill claims, ESCO-aligned, EQF-referenced) supporting cross-institution verification. The project embeds clinical intrapreneurship, training professionals to design and implement sustainable pharmacogenomics services. Recognition is built in through employer governance and a ready-to-adopt toolchain enabling hospitals and professional bodies to embed credentials into job profiles.
- Technical Specification or Expertise Sought
- Partners should have expertise in one or more of: pharmacy or medical education (HE); vocational education and training curriculum development; clinical pharmacogenomics or genomic medicine; bioinformatics and genomic data analysis; clinical genetics laboratory management; hospital pharmacy management; pharmaceutical R&D; digital health and electronic health records; AI-enabled clinical decision support systems; ESCO occupational profile development; micro-credential design and quality assurance.
- Stage of Development
- Under development
- Sustainable Development Goals
- Goal 9: Industry, Innovation and Infrastructure
- Goal 3: Good Health and Well-being
- Goal 4: Quality Education
- Goal 8: Decent Work and Economic Growth
- Goal 17: Partnerships to achieve the Goal
Partner Sought
- Expected Role of a Partner
- Partners are expected to contribute to one or more work packages: (WP2) skills needs analysis and ESCO occupational profile development for Clinical Pharmacogenomics Specialist and Genomic Laboratory Technician; (WP3) co-design and development of HE and VET curricula, including real-world case studies and workplace scenarios; (WP4) development of micro-credential programme and digital credential infrastructure; (WP5) piloting curricula with learners at partner institutions and providing employer feedback for validation; (WP6) dissemination, exploitation and sustainability activities. Enterprise partners (hospital pharmacies, clinical genetics laboratories, pharmaceutical companies) are especially sought to contribute workplace expertise and real-world case studies. HEI and VET providers are sought to host curriculum pilots and ensure quality assurance. The type of partnership is a research and development cooperation agreement.
- Type and Size of Partner
- Big company
- SME 50 - 249
- University
- Type of partnership
- Research and development cooperation agreement
Call details
- Framework program
- ERASMUS+
- Call title and identifier
-
Alliances for Innovation - Lot 1: ERASMUS-EDU-2026-PI-ALL-INNO-EDU-ENTERP
- Submission and evaluation scheme
-
Single-stage full application
- Anticipated project budget
-
1500000
- Coordinator required
-
Yes
- Deadline for EoI
- Deadline of the call
- Project duration in weeks
-
156
- Web link to the call
- https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-details/ERASMUS-EDU-2026-PI-ALL-INNO-EDU-ENTERP
- Project title and acronym
-
Genomic Pharmacy & Personalised Medicine Skills Innovation Alliance - GENIA
- ERASMUS+
Dissemination
- Technology keywords
- 06003001 - Bioinformatics
- 11002 - Education and Training
- Market keywords
- 07005004 - Education and educational products and materials
- 04014 - Bioinformatics
- 05005008 - Internal medicine
- 05007007 - Other medical/health related (not elsewhere classified)
- Sector Groups Involved
- Digital
- Health
- Targeted countries
- Afghanistan
- Aland Islands
- Albania
- Algeria
- American Samoa
- Andorra
- Angola
- Anguilla
- Antarctica
- Antigua and Barbuda
- Aruba
- Australia
- Austria
- Azerbaijan
- Bahamas
- Bahrain
- Bangladesh
- Barbados
- Belarus
- Belgium
- Belize
- Benin
- Bermuda
- Bhutan
- Bolivia
- Bonaire, Saint Eustatius and Saba
- Bosnia and Herzegovina
- Botswana
- Bouvet Island
- Brazil
- British Indian Ocean Territory
- British Virgin Islands
- Brunei
- Bulgaria
- Burkina Faso
- Burundi
- Cabo Verde
- Cambodia
- Cameroon
- Canada
- Cayman Islands
- Central African Republic
- Chad
- Chile
- China
- Christmas Island
- Cocos Islands
- Colombia
- Comoros
- Cook Islands
- Costa Rica
- Croatia
- Cuba
- Curacao
- Cyprus
- Czechia
- Democratic Republic of the Congo
- Denmark
- Djibouti
- Dominica
- Dominican Republic
- Ecuador
- Egypt
- El Salvador
- Equatorial Guinea
- Eritrea
- Estonia
- Eswatini
- Ethiopia
- Falkland Islands
- Faroe Islands
- Fiji
- Finland
- France
- French Guiana
- French Southern Territories
- Gabon
- Gambia
- Georgia
- Germany
- Ghana
- Gibraltar
- Greece
- Greenland
- Grenada
- Guadeloupe
- Guam
- Guatemala
- Guernsey
- Guinea
- Guinea-Bissau
- Guyana
- Haiti
- Heard Island and McDonald Islands
- Honduras
- Hong Kong
- Hungary
- Iceland
- India
- Indonesia
- Iran
- Iraq
- Ireland
- Isle of Man
- Israel
- Italy
- Ivory Coast
- Jamaica
- Japan
- Jersey
- Jordan
- Kazakhstan
- Kenya
- Kiribati
- Kosovo
- Kuwait
- Kyrgyzstan
- Laos
- Latvia
- Lebanon
- Lesotho
- Liberia
- Libya
- Liechtenstein
- Lithuania
- Luxembourg
- Macao
- Madagascar
- Malawi
- Malaysia
- Maldives
- Mali
- Malta
- Marshall Islands
- Martinique
- Mauritania
- Mauritius
- Mayotte
- Mexico
- Micronesia
- Moldova
- Monaco
- Mongolia
- Montenegro
- Montserrat
- Morocco
- Mozambique
- Myanmar
- Namibia
- Nauru
- Nepal
- Netherlands
- Netherlands Antilles
- New Caledonia
- Nicaragua
- Niger
- Nigeria
- Niue
- Norfolk Island
- North Korea
- North Macedonia
- Northern Mariana Islands
- Norway
- Oman
- Pakistan
- Palau
- Palestinian Territory
- Panama
- Papua New Guinea
- Paraguay
- Peru
- Philippines
- Pitcairn
- Poland
- Portugal
- Puerto Rico
- Qatar
- Republic of the Congo
- Reunion
- Romania
- Russia
- Rwanda
- Saint Barthelemy
- Saint Helena
- Saint Kitts and Nevis
- Saint Lucia
- Saint Martin
- Saint Pierre and Miquelon
- Saint Vincent and the Grenadines
- Samoa
- San Marino
- Sao Tome and Principe
- Saudi Arabia
- Senegal
- Serbia
- Seychelles
- Sierra Leone
- Singapore
- Sint Maarten
- Slovakia
- Slovenia
- Solomon Islands
- Somalia
- South Africa
- South Georgia and the South Sandwich Islands
- South Sudan
- Spain
- Sri Lanka
- Sudan
- Suriname
- Svalbard and Jan Mayen
- Sweden
- Switzerland
- Syria
- Taiwan
- Tajikistan
- Tanzania
- Thailand
- Timor Leste
- Togo
- Tokelau
- Tonga
- Trinidad and Tobago
- Tunisia
- Türkiye
- Turkmenistan
- Turks and Caicos Islands
- Tuvalu
- U.S. Virgin Islands
- Uganda
- Ukraine
- United Arab Emirates
- United States
- United States Minor Outlying Islands
- Uruguay
- Uzbekistan
- Vanuatu
- Vatican
- Venezuela
- Vietnam
- Wallis and Futuna
- Western Sahara
- Yemen
- Zambia
- Zimbabwe